CLL
Conference Coverage
Studies address ibrutinib bleeding risk in patients with CLL receiving Mohs surgery
Mohs surgeons may commonly find themselves treating patients with these unique considerations.
From the Journals
Phase-3 study: Leukemia patients live longer with ibrutinib
RESONATE-2 trial data show durable improvements for chronic lymphocytic leukemia (CLL) patients, even those with high-risk genomic features.
Feature
Third-generation Black woman physician makes cancer research history
African American surgeon helped found ASCO and collaborated with her father to achieve lasting breakthroughs in chemotherapy.
Feature
Ex–hospital porter a neglected giant of cancer research
An Indian immigrant who once emptied bedpans in a Boston hospital went on to become the “father of chemotherapy.”
From the Journals
‘Agony of choice’ for clinicians treating leukemia
Novel targeted therapies emerge as frontline options while chemoimmunotherapy “fades into the background.”
Conference Coverage
Zanubrutinib shows worth against standard CLL drugs
New CLL drug demonostrates its efficacy in the crowded field of CLL treatment options.
Feature
When CPI fails, HL patients should get timely allo-HCT
New data suggest that physicians should refer Hodgkin lymphoma patients for allogeneic HCT without delay when PD-1 treatments fail.
Feature
Survivor’s story foreshadows one of oncology’s greatest successes
In 1992, a young New Yorker was among the first Hodgkin lymphoma patients to undergo a successful bone marrow transplant. Three decades later,...
From the Journals
Some leukemias detectable up to 16 years before diagnosis?
Sequencing analysis showed that even high-risk CLL subtypes precursor states may exist up to 16 years longer than previously thought.
Commentary
A little-known offshoot of hem/onc opens pathway for professional development
Among hematologist oncologists, discussion and research is underway on how we evaluate and treat vascular anomalies--a fertile area for...
From the Journals
Eating olive oil may slow CLL disease progression
A pilot study in Greece suggested that consuming extra virgin olive oil daily induced the apoptosis of cancer cells.